The association of angiotensin-converting enzyme gene insertion/deletion polymorphisms with OSA: a meta-analysis Source: Eur Respir J 2012; 40: 394-399 Year: 2012
Effect of angiotensin converting enzyme (ACE) gene polymorphism on diaphragmatic endurance in neonates Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008
Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD Source: Eur Respir J 2007; 29: 816-817 Year: 2007
Genotype-corrected reference values for serum angiotensin-converting enzyme Source: Eur Respir J 2006; 28: 1085-1091 Year: 2006
Activity and phenotypes of angiotensin-converting enzyme (ACE) in sarcoidosis with various organ involvement Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS Source: Eur Respir J 2007; 29: 482-488 Year: 2007
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population Source: Eur Respir J 2006; 27: 1217-1222 Year: 2006
ACE gene I/D polymorphism in sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010
ACE gene I/D polymorphism and initial disease presentation in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 75s Year: 2003
Angiotensin-converting enzyme insertion/deletion gene polymorphism and interstitial pulmonary fibrosis in Iranian population Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
Effect of ACE gene polymorphism on quadriceps strength in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 233s Year: 2004
Clinical significance of angiotensin converting enzyme (ACE) activity in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001
Impact of statins, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARBS) on reducing COPD morbidity Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Polymorphisms of ACE gene in airflow limited patients with or without reversibility Source: Eur Respir J 2004; 24: Suppl. 48, 585s Year: 2004
No association of angiotensin I-converting enzyme gene polymorphism and pulmonary function in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003
Correlation between the use of statins and ACE inhibitors with the length of hospitalization for COPD exacerbations Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Impact of statins, angiotensin-converting enzyme inhibitors(ACEI), and angiotensin receptor blockers (ARBs) on reducing COPD morbidity Source: Annual Congress 2010 - COPD: management Year: 2010
Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Effect of long-term angiotensin-converting factor inhibitors on breathing function and hemorheology indices in patients with tuberculosis and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 306s Year: 2001
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia Source: Eur Respir J 2008; 31: 611-617 Year: 2008